FDA approves cellular therapy, offering hope to more people with cancer
The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma that has spread to other parts of the body (metastatic). It’s the first time a cellular therapy has received approval to treat solid tumors and offers the potential to be used as a treatment for other solid cancers.
The FDA gave fast-track approval to AMTAGVI (lifileucel) an autologous adoptive cell transfer therapy, based on the safety and efficacy results of a phase II clinical trial in patients with metastatic melanoma. Providence Cancer Institute of Oregon was among the first sites to enroll patients in this global study.
“It's taken a long time to learn how to manipulate a very complex [immune] system. But we're getting better at doing that in a way that helps our patients,” says Brendan Curti, M.D., medical director, Melanoma Program, Cytokine and Adoptive Immunotherapy, and Robert W. Franz Endowed Chair for Clinical Research at Providence Cancer Institute. Dr. Curti was the principal investigator at Providence Cancer Institute on the lifileucel study, known as LN-144.
Learn more about this groundbreaking news.
Pink Lemonade Project and PCI, March 5: FREE virtual education talk by Christina Speaks, registered dietitian, PCI Oncology Nutrition, on food and common cancer cancer myths.
Register for this event.
Pink Lemonade Project MBC Virtual Presentation, March 7: will feature Alison Conlin, M.D., medical director, Providence Breast Cancer Program, at a free virtual discussion for those affected by metastatic breast cancer. Dr. Conlin will provide updates from the 2023 AACR/San Antonio Breast Cancer Symposium. The first hour of this event is for socializing online.
Pink Lemonade Project MBC Virtual Presentation will feature Alison Conlin, M.D., medical director, Providence Breast Cancer Program, at a free virtual discussion for those affected by metastatic breast cancer. Dr. Conlin will provide updates from the 2023 AACR/San Antonio Breast Cancer Symposium. The first hour of this event is for socializing online followed by the presentation at 7 p.m. Register for this event.
Heart Month: Heart failure and heart care
KATU News Family Matters story with Dr. Lori Tam: https://youtu.be/1nN_h916zbk
About the Author
More Content by Providence inScope Content Team
